OnKure Therapeutics, Inc. Stock Price

NasdaqGM:OKUR Community·US$143.8m Market Cap

0 Narratives written by author
0 Comments on narratives written by author
5 Fair Values set on narratives written by author

Create a narrative

OKUR Share Price Performance

US$4.07

1.92 (89.30%)

US$4.07

1.92 (89.30%)

US$4.07

Fri, 22 May 26

Share Pricen/a

OKUR Community Narratives

There are no narratives available yet.

Create a narrative

There are no community narratives available.

Trending Discussion

Snowflake Analysis

Flawless balance sheet with moderate risk.

5 Risks

1 Reward

View Full Analysis

OnKure Therapeutics, Inc. Key Details

Last Reported Earnings

Mar 31, 2026

Next Reporting Earnings

n/a

: -1.45
: 0%
: 0%
: 0%

View Full Analysis

About OKUR

Founded: 2011
Employees: 45
CEO: Nicholas Saccomano
WebsiteView website: onkuretherapeutics.com

OnKure Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of precision medicines that target biologically validated drivers of cancers and other diseases. Its lead product candidate includes OKI-219, a selective inhibitor of phosphoinositide 3-kinase alpha (PI3Ka) harboring the H1047R mutation that is in Phase 1 clinical trial for the treatment of solid tumors, including breast cancer. The company was founded in 2011 and is headquartered in Boulder, Colorado.